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Functional interaction of Src family kinases with the
acetylcholine receptor in C2 myotubes
Abstract
Tyrosine phosphorylation of the beta subunit of the acetylcholine receptor (AChR) has been postulated
to play a role in AChR clustering during development of the neuromuscular junction. We have
investigated the mechanism of this phosphorylation in mammalian C2 myotubes and report that the
tyrosine kinase Src binds and phosphorylates glutathione S-transferase fusion proteins containing the
N-terminal half of the cytoplasmic loop of the beta subunit. No binding occurs to the related kinases Fyn
or Yes or to the corresponding regions from the gamma and delta subunits. Furthermore, AChRs
affinity-isolated from C2 myotubes using alpha-bungarotoxin-Sepharose were specifically associated
with Src and Fyn and had tyrosine-phosphorylated beta subunits. We suggest that AChRs are initially
phosphorylated by Src and subsequently bind Fyn in a phosphotyrosine-dependent manner. These
interactions are likely to play an important role in construction of the specialized postsynaptic
membrane during synaptogenesis.
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Tyrosine phosphorylation of the b subunit of the ace-
tylcholine receptor (AChR) has been postulated to play a
role in AChR clustering during development of the neu-
romuscular junction. We have investigated the mecha-
nism of this phosphorylation in mammalian C2 myo-
tubes and report that the tyrosine kinase Src binds and
phosphorylates glutathione S-transferase fusion pro-
teins containing the N-terminal half of the cytoplasmic
loop of the b subunit. No binding occurs to the related
kinases Fyn or Yes or to the corresponding regions from
the g and d subunits. Furthermore, AChRs affinity-iso-
lated from C2 myotubes using a-bungarotoxin-Sepha-
rose were specifically associated with Src and Fyn and
had tyrosine-phosphorylated b subunits. We suggest
that AChRs are initially phosphorylated by Src and sub-
sequently bind Fyn in a phosphotyrosine-dependent
manner. These interactions are likely to play an impor-
tant role in construction of the specialized postsynaptic
membrane during synaptogenesis.
Protein-tyrosine phosphorylation is a widely used mecha-
nism for regulating cellular functions, particularly those in-
volving growth or differentiation factors. Several protein-ty-
rosine kinases are highly expressed in brain (1–3) and are
associated with synaptic structures (4), suggesting that they
play a general role in synaptic function. At the neuromuscular
junction and at its homologous synapse in the electric organ of
Torpedo, tyrosine phosphorylation appears to be important for
regulating both the function and the distribution of the nico-
tinic acetylcholine receptor (AChR)1 during development (5, 6).
The AChR is a ligand-gated ion channel with a pseudosym-
metric pentameric structure consisting of four homologous sub-
units in the ratio a2bgd. Each subunit traverses the membrane
four times, with a long, cytoplasmic loop between transmem-
brane domains 3 and 4 (7, 8). In the Torpedo AChR, a single
conserved tyrosine residue in the cytoplasmic loop of each of
the b, g, and d subunits is phosphorylated by a kinase activity
in the postsynaptic membrane (9). In this tissue, two members
of the Src family of tyrosine kinases, Fyn and Fyk, account for
a substantial fraction of the total tyrosine kinase activity and
have been shown in immunoprecipitation experiments to be
associated with tyrosine-phosphorylated AChRs (10, 11). Phos-
phorylation of the AChR subunits is accompanied by an in-
crease in the rate of rapid desensitization of the receptor by
cholinergic ligands, a change that is also produced by phospho-
rylation of the receptor on serine residues (12, 13).
Tyrosine phosphorylation of the AChR appears to play an
important role in synaptogenesis. At the mammalian neuro-
muscular junction, tyrosine phosphorylation in the postsynap-
tic membrane, possibly of the AChR, increases during the late,
post-natal stage of synaptic maturation (14). Tyrosine phospho-
rylation of the AChR may also be related to one of the earliest
steps in synapse formation, the clustering of AChRs in the
postsynaptic membrane underlying the nerve terminal (5).
Studies on the development of the chick neuromuscular syn-
apse have shown that the earliest detectable AChR clusters in
vivo contain phosphotyrosine and that in vitro AChR clustering
and phosphotyrosine co-staining in chick myotubes depend on
innervation by co-cultured neurons (15). Both in nerve-muscle
cultures and in vivo, the aggregation of AChRs at the nascent
neuromuscular junction is caused by agrin released from motor
nerves (16, 17). The addition of agrin to cultured myotubes
induces both widespread AChR cluster formation and tyrosine
phosphorylation of the AChR (15, 18, 19). In mammalian mus-
cle, this phosphorylation, which is specific for the b subunit of
the receptor, reaches a peak in 1 h and precedes AChR clus-
tering (20). The kinase inhibitors herbimycin A and staurospo-
rine block both AChR phosphorylation and AChR clustering
(20, 21). A receptor tyrosine kinase, MuSK, which is localized to
synapses in adult muscle, appears to be part of the signaling
receptor for agrin (22). Activation of MuSK also results in
tyrosine phosphorylation of the AChR (23, 24).
The protein-tyrosine kinase or kinases that are responsible
for phosphorylating the AChR in mammalian muscle cells are
unknown. We report here experiments to identify the kinase(s)
responsible for tyrosine phosphorylation of the AChR and to
examine the interaction of Src family kinases with the AChR in
mammalian muscle. Our results show that Src from C2 myo-
tubes selectively binds to fusion proteins derived from the long,
intracellular loop of the AChR b subunit; by immunodepletion
and in vitro phosphorylation we find that bound Src phospho-
rylates the fusion proteins. We also show that AChRs isolated
from C2 myotubes are tyrosine-phosphorylated on their b sub-
units and are associated with two members of the Src family,
Fyn and Src. We describe a model for the interaction between
the AChR and the Src family members and suggest that these
kinases are likely to play a role in the construction of a postsyn-
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aptic complex and immobilization of the AChR at developing
synapses.
EXPERIMENTAL PROCEDURES
Generation of GST Fusion Proteins—Glutathione S-transferase fu-
sion proteins containing segments of the long cytoplasmic loop of the
AChR subunits were generated using cDNAs encoding the a, b, and d
subunits of the mouse muscle nicotinic AChR in the vector pSM (25) as
templates. AChR segments were amplified using the polymerase chain
reaction in combination with oligonucleotides that bordered the do-
mains of interest and were designed to create a 59 BamHI and a 39
EcoRI restriction site. Amplified DNA segments were isolated, digested
with BamHI and EcoRI, and ligated into pGEX-2T vectors (Pharmacia
Biotech Inc.) cleaved with the same enzymes. Polymerase chain reac-
tion-amplified DNA inserts were control sequenced using a commer-
cially available dideoxy sequencing kit from U.S. Biochemical Corp. In
the resulting fusion proteins, the AChR segments are fused to the C
terminus of GST. DNA constructs were used to transform E. coli
HB101. Large scale cultures were grown, induced with isopropyl-b-D-
thiogalactopyranoside, sonicated on ice, and the GST fusion proteins
purified on glutathione-Sepharose beads (26) and stored coupled to the
beads at 4 °C. The concentration of the fusion proteins was estimated by
SDS-polyacrylamide electrophoresis (SDS-PAGE), protein staining
with Coomassie Blue (Sigma), and comparison to a bovine serum albu-
min standard (Pierce). The following fusion proteins were prepared (see
also Fig. 2; numbers indicate positions of amino acids within the full-
length subunits including the N-terminal signal sequence): bA,9,10,B
(b subunit, amino acids 333–469); bA,9,10 (b subunit, amino acids
333–455); bA,9 (b subunit, amino acids 333–405); b9 (b subunit, amino
acids 349–405); b9,10 (b subunit, amino acids 349–455); b10 (b sub-
unit, amino acids 406–455); g9 (g subunit, amino acids 346–417); d9 (d
subunit, amino acids 353–420). The amino acid sequence (N to C
terminus) of the b exon 9 region in the b9 fusion protein is
IFIHKLPPYLGLKRPKPERDQLPEPHHSLSPRSGWGRGTDEYFIRK-
PPSDFLFPKLN. The corresponding sequence of g9 is LFLRL-
RPQLLRMHVRPLAPAAVQDARFRLQNGSSSGWPIMAREEGDLCLP-
RSELLFRQRQRNGLVQAVLEKL, and the homologous sequence of d9
is FFLETLPKLLHMSRPAEEDPGPRALIRRSSSLGYICKAEEYFSLK-
SRSDLMFEKQSERHGLARRLTTA.
Cell Culture—C2C12 mouse muscle cells were cultured on 10- or
15-cm plastic dishes (Nunc) as described previously (27). All cell culture
reagents were purchased from Life Technologies, Inc. Cells were prop-
agated at low density in growth medium consisting of Dulbecco’s mod-
ified Eagle’s medium with 4.5 g/liter D-glucose supplemented with 20%
fetal bovine serum, 0.5% chick embryo extract, 2 mM glutamine, and
penicillin/streptomycin. Cultures at about 90% confluence were induced
to form myotubes by changing the medium to differentiation medium
consisting of Dulbecco’s modified Eagle’s medium containing 5% horse
serum and 2 mM glutamine. Fusion of myoblasts to generate myotubes
was evident after 1 day, and contracting myotubes were usually ob-
served after 2 days by which time the cultures were used for
experiments.
Kinase Binding Assays and Kinase Expression—Myotubes grown on
10-cm dishes were rinsed at 4 °C with phosphate-buffered saline sup-
plemented with 1 mM sodium orthovanadate and 50 mM NaF and
extracted in 1 ml of lysis buffer containing 1% Nonidet P-40, 150 mM
NaCl, 10 mM triethanolamine, pH 7.6, 5 mM EGTA, 5 mM EDTA, 50 mM
NaF, 1 mM sodium orthovanadate, and protease inhibitors (1 mM ben-
zamidine, 1 mM N-ethylmaleimide, 1 mM sodium tetrathionate, 1 mM
phenylmethylsulfonyl fluoride, 25 mg/ml aprotinin, and 25 mg/ml leu-
peptin). Insoluble material, such as nuclei and extracellular matrix,
was removed by centrifugation at 18,000 3 g for 5 min. To analyze
binding of fusion proteins to Src-related kinases, lysates were incubated
for 2 h at 4 °C with 2 or 5 mg of fusion proteins adhering to glutathione-
Sepharose beads. Beads were then washed twice in wash buffer 1 (0.4%
Nonidet P-40, 500 mM NaCl, 10 mM triethanolamine, pH 7.6, 5 mM
EGTA, 5 mM EDTA, 1 mM sodium orthovanadate, 1 mM phenylmethyl-
sulfonyl fluoride), twice in wash buffer 2 (same as 1, but containing 150
mM NaCl), and boiled in SDS-PAGE sample buffer. Samples were
analyzed by reducing SDS-PAGE and immunoblotting using nitrocel-
lulose (Micron Separations Inc.) and specific antibodies against Src
(mouse monoclonal, Oncogene Science Inc.), Fyn (rabbit polyclonal,
Santa Cruz Biotech), Yes (mouse monoclonal, Wako Chemicals), or with
src-CT antiserum (rabbit polyclonal, Santa Cruz Biotech). Immunore-
active bands were visualized with horseradish peroxidase-conjugated
secondary antibodies and enhanced chemiluminescence (ECL; Amer-
sham Corp.). To analyze expression of Src, Fyn, and Yes in total ex-
tracts of C2 myotubes, aliquots of cleared lysates were subjected to
SDS-PAGE and immunoblotting with the antibodies mentioned above.
Alternatively, Src-related kinases were first immunoprecipitated with 1
mg of src-CT, Src, Fyn, and Yes antibodies followed by protein A- or
protein G-Sepharose. Precipitates were then analyzed by nonreducing
SDS-PAGE and immunoblotting with src-CT. To reprobe immunoblots,
they were stripped as described (20) using 200 mM glycine, 0.1% Tween
20, pH 2.5, for 20 min and then reprobed with antibodies against GST
(mouse monoclonal, Santa Cruz Biotech) to confirm that equal amounts
of fusion proteins were present in all samples. For some experiments, a
concentrated membrane fraction of C2 myotubes (18, 28) was used for
fusion protein adsorption. Briefly, myotubes grown on 15-cm dishes
were homogenized in a lysis buffer without detergent, centrifuged at
6000 3 g to remove nuclei and unbroken cells, and then centrifuged at
100,000 3 g for 30 min. The pelleted membranes were extracted in 200
ml of lysis buffer containing 1% Nonidet P-40 and centrifuged again at
100,000 3 g for 30 min. The supernatant, consisting of concentrated C2
myotube membranes, was then analyzed as described above. Quantita-
tion of ECL immunoblotting data was performed by scanning the films
with a computerized densitometer (Sierra Scientific) and using the NIH
Image 1.54 software (National Institutes of Health).
In Vitro Phosphorylation and Kinase Depletion—To analyze the ca-
pability of Src to phosphorylate bound b9 fusion proteins, C2 myotube
extracts were first adsorbed with fusion protein beads as mentioned
above. Beads were then washed twice in kinase assay buffer (20 mM
Tris, pH 7.4, 10 mM MgCl2, 2 mM sodium orthovanadate, 1 mM phen-
ylmethylsulfonyl fluoride) and incubated for 15 min at 37 °C with
kinase assay buffer containing 3 mM ATP. Beads were pelleted and
boiled in SDS-PAGE sample buffer. To visualize tyrosine phosphoryla-
tion, samples were subjected to SDS-PAGE and immunoblotting using
an anti-phosphotyrosine antibody, 4G10 (mouse monoclonal, UBI), and
ECL. For immuno-depletion of Src-related kinases, C2 extracts were
incubated for 2 h at 4 °C with src-CT or antibodies specific for Src, Fyn,
and Yes. Antibodies were removed by two rounds of precipitation with
protein A- or protein G-Sepharose. Depleted lysates were then adsorbed
with fusion proteins as described before. To analyze the ability of
purified Src kinase to phosphorylate the b9 fusion protein, fusion pro-
teins were first eluted from glutathione-Sepharose using 5 mM reduced
glutathione in 50 mM Tris, pH 7.5, and 2 mM EDTA and dialyzed into
the same buffer lacking glutathione. 5 mg of fusion proteins were then
incubated with 5 ng of baculovirus-expressed and purified Src kinase (a
gift from Dr. D. Morgan, University of California, San Francisco, CA) in
a volume of 40 ml of phosphorylation buffer (0.5 mCi/ml [g-32P]ATP, 10
mM ATP, 20 mM Hepes, pH 7.4, 1 mM dithiothreitol, 10 mM MgCl2, 100
mM NaCl) for 1–24 h at 4, 25, or 37 °C. Reactions were stopped by
boiling in SDS-PAGE sample buffer and analyzed by SDS-polyacryl-
amide gel electrophoresis and autoradiography. For quantitation, the
b9 protein bands (;34 kDa) were excised from dried gels and analyzed
by liquid scintillation counting. As background we measured pieces of
the gels not containing any proteins. Comparison of the amount of
incorporated 32P with the amount of b9 fusion protein allowed us to
calculate the percentage of fusion proteins phosphorylated in the
reactions.
Isolation of AChRs —To assay association of endogenous Src-related
kinases with the AChR in C2 myotubes, cells were grown and lysed as
mentioned above with the exception of Nonidet P-40 which was re-
placed by digitonin in most experiments. The solubilized AChR was
isolated as described (20) by incubating the extracts with a-bungaro-
toxin (Sigma) conjugated to Sepharose beads (Sigma). As a control for
specificity, we added excess (10 mM) free uncoupled a-bungarotoxin.
Other control samples were precipitated with uncoupled Sepharose
beads. Precipitates were washed as before and the proteins isolated on
the beads eluted in SDS-PAGE sample buffer, either by boiling or at
room temperature. Analysis by SDS-PAGE and immunoblotting with
antibodies against Src-related kinases was performed as mentioned.
Stripped immunoblots were reprobed with anti-phosphotyrosine anti-
bodies (4G10, in a few experiments with PY20 (mouse monoclonal;
Transduction Labs)). To reveal the AChR, the blots were stripped and
reprobed a second time using mAB 124 which recognizes the AChR b
subunit (rat monoclonal; a kind gift from Dr. J. Lindstrom, University
of Pennsylvania, Philadelphia, PA).
RESULTS
Expression of Src Family Kinases in C2 Myotubes—In our
initial experiments we examined C2 myotubes for the expres-
sion of three prominent Src family kinase members, Src, Fyn,
and Yes. In contrast to other Src-related kinases that are
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restricted to particular cell types, these kinases show a wide-
spread tissue distribution and are thought to be involved in a
variety of cellular signal transduction pathways (29, 30). Ex-
tracts of C2 myotube cultures were immunoblotted with an
antiserum, src-CT, that recognizes a highly conserved sequence
at the extreme C terminus of all three kinases, and with anti-
bodies specific for each of the kinases (Fig. 1A). All three
kinases were found in the extracts. Each of the kinases was
also immunoprecipitated from C2 extracts as shown by immu-
noprecipitation with the specific antisera followed by immuno-
blotting with src-CT (Fig. 1B). Thus each of the Src family
members examined is present in C2 myotubes and is recog-
nized by src-CT in immunoblot assays.
Fusion Proteins Containing the b Subunit Cytoplasmic
Loop—We then constructed GST fusion proteins containing all
or part of the cytoplasmic loop connecting transmembrane do-
mains 3 and 4 of the b subunit of the mouse muscle AChR (Fig.
2). The gene encoding the b subunit contains two exons, 9 and
10, that together encode most of the loop (31). The fusion
protein b9 covers exon 9, whereas the fusion proteins b10 and
b9,10 contain the products of exon 10 and both exon 9 and exon
10, respectively (Fig. 2). The region encoded by exon 9, which is
N-terminal, contains two tyrosine residues. One of these (Tyr-
390), which is conserved between species, is phosphorylated in
the AChR isolated from the Torpedo electric organ (9). Exon 10
encodes most of the C-terminal half of the loop which contains
a third tyrosine as well as the amphipathic helix (32). As
controls we made fusion proteins with sequences from the
cytoplasmic loops of the AChR g and d subunits that correspond
to the exon 9 region of the b subunit (g9 and d9 proteins).
Whereas the g region lacks tyrosine residues, the d region
contains two, one of which is homologous to Tyr-390 of the b
subunit and is phosphorylated in the Torpedo AChR (9).
The N-terminal Half of the AChR b Subunit Loop Specifically
Interacts with Src—To determine whether the b loop of the
AChR interacts with members of the Src family, Nonidet P-40
extracts of C2 myotubes were incubated with purified GST b
fusion proteins adhering to glutathione-Sepharose beads.
Bound kinases were identified by elution of the beads with SDS
buffer, followed by SDS-gel electrophoresis and immunoblot-
ting. Experiments with src-CT showed that one or more Src
family member(s) bound to fusion proteins containing the b
subunit exon 9 region, but not to a fusion protein containing
only b exon 10 (b10) nor to GST alone (Fig. 3A). Apparent
differences in the extent of binding to Src kinase(s) between b
exon 9-containing fusion proteins (Fig. 3A) were not reproduc-
ible over the course of several experiments and may be related
to variations in the folding efficiency of the different fusion
proteins. Binding to the b exon 9 region was specific, however,
as interactions with b10 or GST were not observed, even when
large amounts (20 mg) of fusion proteins and long immunoblot
exposure times were used. In control experiments, the ability of
the AChR g and d subunits to bind to Src-related kinases was
tested using the g9 and d9 fusion proteins (Fig. 3B). No binding
was detected to the g9 region, consistent with the absence of
tyrosine residues. Surprisingly, the d9 region, which contains
FIG. 1. Expression of Src-related kinases in C2 myotubes and
characterization of kinase-specific antibodies. A, C2 myotubes
grown on 10-cm dishes were lysed in a buffer containing 1% Nonidet
P-40, and the indicated fractions of the extracts were analyzed by
reducing SDS-PAGE and immunoblotting as described under “Experi-
mental Procedures.” Nitrocellulose blots were incubated with antibod-
ies specific for Src, Fyn, or Yes or with an antiserum, src-CT, that
recognizes all three. Arrowheads indicate the position of Src-related
kinases. Under reducing conditions, all three kinases show essentially
the same mobility. Src-CT and Fyn antibodies also react with unknown
proteins of ;90 and ;100 kDa, respectively. B, C2 myotube extracts
were subjected to immunoprecipitation with 1 mg of the indicated an-
tibodies followed by protein A- or protein G-Sepharose. Immunoprecipi-
tates (IP) were analyzed by nonreducing SDS-PAGE and immunoblot-
ting with src-CT. A fraction of the initial lysate (L) was included for
comparison. As src-CT and Fyn antisera are both from rabbit, whereas
anti-Src and Yes are mouse monoclonal antibodies, immunoglobulin
molecules (;150 kDa) and Ig heavy chains (;50 kDa) appear in the first
two lanes (marked by asterisks). After immunoprecipitation and anal-
ysis with nonreducing SDS-PAGE, Yes displays a slightly slower mo-
bility than Src or Fyn. All three kinases are recognized by src-CT
antiserum on immunoblots.
FIG. 2. Sequences of AChR cytoplasmic portion constructs. A,
general transmembrane organization of the AChR b, g, and d subunits.
The long loop between transmembrane domains 3 and 4 accounts for
most of the cytoplasmic portion of the subunits. B, GST constructs
derived from the mouse b, g, and d cytoplasmic loops. Intron/exon
boundaries were previously determined for the mouse b, human, and
chicken g, and chicken d subunits (31, 54, 55). The scheme at the top
represents the loop of the b subunit and shows that most of this domain
is encoded by two exons, exon 9 and exon 10. Two short flanking
regions, termed A and B, account for the rest. Numbers refer to the
position of amino acids within the uncleaved mouse b subunit including
the N-terminal signal sequence. As the amino acid sequences surround-
ing the exon/exon boundaries are highly conserved between species, we
designed g9 and d9 constructs according to the human and chicken
genomic structures. Tyrosine residues are highlighted and names of
constructs are as indicated.
Interaction of AChRs with Src-related Kinases32476
two tyrosine residues, also failed to bind Src family kinases.
Together, these findings indicate that the exon 9 region of the
AChR b subunit specifically binds at least one kinase of the Src
family.
To identify the specific kinase(s) involved, we analyzed the
adsorptions with antibodies specific for Src, Fyn, or Yes. Each
antibody was also tested against the original C2 myotube ly-
sate to allow comparison of the results with different antisera.
As shown in Fig. 4, b9 and b9,10 fusion proteins bound Src, but
no binding was detected for Fyn or Yes. b10, g9, and d9 fusion
proteins failed to bind Src, Fyn, or Yes, confirming the speci-
ficity of the b9-Src interaction. For each kinase the efficiency of
binding to the b9 fusion protein was estimated by comparing
the amount of kinase bound with the total kinase content of the
initial cell lysates as measured by immunoblotting with the
same antibody. With the Src-specific antibody we estimate that
under the conditions of our experiments 5 mg of b9 fusion
protein bound ;1.4% of the Src initially present in the cell
extracts. When more (15 mg) fusion protein was incubated with
a concentrated C2 membrane preparation instead of a total cell
extract, this percentage was increased to about 15%. Using
src-CT on immunoblots the comparable recovery values were
0.5 and 5% for 5 and 15 mg of b9 fusion protein in total extracts
and membrane preparations, respectively (data not shown).
Together, these studies indicate that the b exon 9 fusion pro-
tein specifically binds to Src, but not to Fyn or Yes, and that the
homologous regions from the g and d subunits fail to bind to
any of these three kinases.
The Exon 9 Region of the AChR b Subunit Is Phosphorylated
by Src—To determine whether associated Src is able to phos-
phorylate the b exon 9 region, we adsorbed C2 extracts with b9
fusion protein beads and subsequently incubated the washed
and immobilized Src-b9 complex with ATP under phosphoryl-
ating conditions. Tyrosine phosphorylation was monitored by
immunoblotting with antibodies against phosphotyrosine (Fig.
5). The b9 fusion protein showed a low degree of reactivity with
this antiserum, even in the absence of incubation with ATP
(Fig. 5A, lane 1). The same signal was seen with the g9 fusion
protein, which lacks tyrosine residues in its AChR portion, and
presumably represents nonspecific cross-reactivity of phospho-
tyrosine antibodies with both bacterially expressed proteins.
Upon incubation of the b9 fusion protein with C2 extracts and
subsequently with ATP, two phosphorylated bands were ob-
served, a prominent band of ;34 kDa and a minor band of ;60
kDa (Fig. 5A, lane 2). Longer exposures of immunoblots re-
vealed no other bands. Based on their molecular weights and
the results of stripping and reprobing the blots with the appro-
priate antibodies (data not shown), we identified the 34- and
60-kDa bands as the b9 fusion protein and Src, respectively.
When C2 extracts were adsorbed with g9 or with GST protein
beads, followed by incubation with ATP, no specific phospho-
tyrosine staining was observed (Fig. 5A, lanes 16 and 18).
Furthermore, no phosphorylation was detected using d9 or b10
fusion proteins, but strong phosphorylation did occur when the
b9,10 fusion protein was used (data not shown). Thus tyrosine
phosphorylation is specific for the b exon 9 region of fusion
proteins.
To analyze whether this phosphorylation is carried out spe-
cifically by bound Src, we immuno-depleted the C2 lysates with
Src-specific antibodies prior to adsorption. Phosphorylation of
the b9 fusion protein and Src was drastically reduced by de-
pletion with either Src-specific antibodies or with src-CT but
was unchanged when antibodies against Fyn or Yes were used
FIG. 3. Fusion proteins containing the exon 9 region of the
b-cytoplasmic loop bind to a Src-related kinase(s). Nonidet P-40
lysates from C2 myotubes were incubated for 2 h at 4 °C with either 2
or 5 mg of the indicated GST fusion proteins attached to glutathione-
Sepharose. Adsorptions were analyzed by reducing SDS-PAGE followed
by immunoblotting using src-CT antiserum (upper panels). Nitrocellu-
lose blots were stripped and reprobed with an antibody against gluta-
thione S-transferase to confirm that equal amounts of GST fusion
proteins were present in the relevant adsorptions (lower panels). A,
binding of constructs containing portions of the b-cytoplasmic loop to
Src-related kinase(s). Apparent differences in kinase binding efficien-
cies varied between experiments. No binding was seen to b10 and GST.
B, binding capabilities of g and d regions homologous to the exon 9
region in b. Binding of Src-related kinase(s) is only observed for b9
fusion proteins but not for the homologous regions of g or d, even when
5 mg of fusion protein is used. A fraction of the initial cell lysate was
analyzed as a standard (L). Lower molecular weight products in the
lower panels represent degradation products of the GST fusion proteins.
The arrowhead indicates Src-related kinases.
FIG. 4. The exon 9 region of the b-cytoplasmic loop specifically
binds to the tyrosine kinase Src. C2 myotubes grown on 10-cm
dishes were lysed and adsorbed to 5 mg of fusion proteins as described
in the legend to Fig. 3. Kinases (arrowheads) binding to the various
fusion proteins were analyzed by immunoblotting with src-CT and
antibodies specific for Src, Fyn, and Yes. To normalize for different
antibody affinities, a constant fraction (0.25%) of the initial lysate was
included (L). b9 and b9,10 fusion proteins bound to Src, but no compa-
rable binding was observed to Fyn and Yes. Densitometric quantitation
of data revealed that 5 mg of b9 bound to and immobilized ;1.4% of Src
initially present in the cell extracts. Using src-CT to immunoblot, this
value was ;0.5%.
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(Fig. 5A, lanes 5–12). Analysis of the depleted C2 lysates con-
firmed that each antibody removed a substantial fraction of its
corresponding kinase without affecting the others (Fig. 5B).
Src-CT removes all kinases, including Src, to an intermediate
degree, yet depletes the phosphorylating activity slightly better
than the Src-specific antibody. This discrepancy may be due to
preferential depletion by src-CT of the enzymatically active
form of Src in which its C terminus is not engaged in an
intramolecular SH2 domain interaction but is exposed and
therefore more accessible for antibody recognition (33). To-
gether, these results show that the b exon 9 fusion protein is
phosphorylated by bound Src, and, as Src family kinases are
known to phosphorylate themselves, they suggest that phos-
phorylation of bound Src is due to autophosphorylation. To
confirm the ability of Src to phosphorylate the b9 fusion pro-
tein, we incubated the fusion protein with purified Src kinase
and [g-32P]ATP. Phosphorylation of the b9 fusion protein, but
not the parental GST protein, was observed (Fig. 5C). Phospho-
rylation was more efficient at 25 or 37 °C than at 4 °C (Fig. 5D);
under optimal conditions, 24 h at 25 °C, about 1% of the b9
fusion protein was phosphorylated.
Src and Fyn Are Bound to the AChR in C2 Myotubes—To
determine whether Src interacts with the AChR in vivo as it
does with the b subunit fusion proteins in vitro, we examined
the AChR purified from muscle cells for associated Src family
kinases. C2 myotube cultures were extracted with a mild de-
tergent (1% digitonin or Nonidet P-40) and the AChRs precip-
itated using a-bungarotoxin conjugated to Sepharose beads.
The beads were then stripped under denaturing conditions and
the proteins analyzed by SDS-PAGE and immunoblotting.
When immunoblots were probed with src-CT (Fig. 6A), a Src
family kinase was observed. The kinase was not observed when
uncoupled Sepharose beads were used as a control nor when
binding of the AChR to the beads was blocked by preincubation
of the receptor in the cell lysates with free toxin. Thus the
presence of the Src family kinase on the beads was dependent
on its association with the AChR. Accordingly, the Src kinase
was seen on immunoblots only when the AChR was also pres-
ent, as observed by stripping the blots and reprobing them with
an antibody to the b subunit (Fig. 6C). In contrast, a contam-
inating src-CT reactive band of ;90 kDa and unknown identity
was isolated under all conditions tested. Stripped immunoblots
were also analyzed with antibodies to phosphotyrosine. Two
bands were consistently seen (Fig. 6B), a 50-kDa band whose
mobility was identical to the b subunit of the AChR (Fig. 6C)
and a 60-kDa band with the same mobility as the Src-related
kinase seen with src-CT (Fig. 6A). A third band of ;110 kDa
(Fig. 6B) was not consistently observed. Tyrosine phosphoryl-
ation of certain proteins, such as the d subunit of the AChR in
chick, is reported to be sensitive to degradation during boiling
in SDS loading buffer (15). However, we did not see additional
phosphotyrosine bands specifically precipitated by a-bungaro-
toxin-Sepharose beads, even when unboiled samples were used
and when immunoblots were analyzed with an alternative
phosphotyrosine antiserum (data not shown).
The identity of the Src-related kinase(s) associated with the
AChR was determined on immunoblots using the kinase-spe-
cific antibodies. As shown in Fig. 7, two kinases were specifi-
cally co-isolated with the AChR, Fyn and Src; no detectable Yes
was seen. Under these conditions, the fraction of each kinase
associated with the AChR was small: approximately 0.04% of
the total Fyn and 0.01% of the total Src in the extract were
recovered with the AChR from a-bungarotoxin-Sepharose. By
comparing the amount of isolated AChR to the receptor content
of the initial lysate, on the other hand, we estimate that we
recover only about 4% of the total AChR in the extract (data not
FIG. 5. The exon 9 region of the b-cytoplasmic loop is tyrosine-
phosphorylated by Src. To determine whether bound Src phospho-
rylates the b exon 9 region, in vitro tyrosine phosphorylation of b9
adsorbates and the effect of kinase depletion were analyzed. For kinase
depletion, C2 myotube lysates were incubated with 1 or 5 mg of src-CT,
Src, Fyn, or Yes antisera (lanes 5–12). Antibodies with bound kinases
were removed by two rounds of precipitation with protein A- or protein
G-Sepharose. In control experiments, incubation with antibodies was
omitted (lanes 1–4, 13–18). Depleted and control lysates were then
incubated with 5 mg of b9, g9, or GST proteins as indicated. Adsorbates
(except lanes 1, 3, 15, and 17) were subjected to in vitro phosphorylation
with ATP. A, tyrosine phosphorylation of fusion proteins and associated
proteins was visualized by reducing SDS-PAGE and anti-phosphoty-
rosine immunoblotting. B, aliquots of control and depleted cell lysates
were analyzed by immunoblotting with specific antibodies against Src,
Fyn, and Yes (open arrowheads) to reveal the degree of kinase depletion
prior to adsorption with fusion proteins. Phosphorylation and depletion
assays show that b9 (but not g9 or GST) and an interacting protein of
;60 kDa (Src; solid arrowheads) become tyrosine-phosphorylated and
that Src, but not Fyn or Yes, accounts for most of this activity. Residual
activity in Src-depleted lysates is somewhat higher than after kinase
removal with src-CT. This difference may originate from src-CT anti-
serum preferentially binding to the more exposed C terminus of kinase
active Src. Lanes 1 and 3 and 2 and 4 are duplicates. PAS and PGS,
protein A- and protein G-Sepharose, respectively. C, phosphorylation of
b9 by purified Src. Isolated Src kinase was incubated for 3 h at 25 °C
with 5 mg of b9, GST, or no substrate under phosphorylating conditions
including [g-32P]ATP. Autoradiography reveals that b9 (;34 kDa) and
Src (;60 kDa), but not GST, become phosphorylated efficiently. D, time
and temperature dependence of Src-mediated b9 phosphorylation.
Phosphorylated b9 protein bands were excised from SDS-polyacryl-
amide gels and quantitated by liquid scintillation counting. Phospho-
rylation reaches a plateau after about 5 h at 25 or 37 °C.
Interaction of AChRs with Src-related Kinases32478
shown). Therefore we calculate that in C2 myotubes about 1%
of the total Fyn and about 0.25% of the total Src are associated
with AChRs. Taken together these experiments show that the
AChRs in C2 myotubes contain tyrosine-phosphorylated b sub-
units and are specifically associated with two tyrosine kinases
of the Src family, Src and Fyn.
DISCUSSION
We have investigated the mechanism by which the AChR
becomes tyrosine-phosphorylated in mammalian C2 myotubes
and find that the tyrosine kinase Src associates with, and
phosphorylates, the region encoded by exon 9 in the N-terminal
half of the cytoplasmic loop of the b subunit of the AChR. In
addition, AChRs isolated from C2 myotubes were specifically
associated with two Src-related kinases, Src and Fyn, and the
AChRs were found to have tyrosine-phosphorylated b subunits.
As judged by several criteria, binding of Src to GST fusion
proteins containing the b exon 9 region was specific. First,
binding of Src to this region occurred in a sequence-specific
way. Binding was not observed to fusion proteins containing
only the C-terminal half of the b loop, encoded by exon 10, nor
to GST protein lacking AChR segments. Second, binding of b
exon 9 fusion proteins specifically occurred to Src, but not to
Fyn or Yes, two other members of the Src family. Third, the
corresponding regions from the g and d subunits of the AChR,
although highly homologous to the exon 9 region of b, did not
show detectable binding to either Src, Fyn, or Yes. Fourth, and
most importantly, the b exon 9 region was a substrate for both
purified Src and for bound Src derived from muscle cell ex-
tracts. Moreover, as the phosphorylation activity was abolished
by immunodepletion of C2 lysates with Src-specific antibodies,
Src appears to be the major, and perhaps the only, tyrosine
kinase in C2 myotubes that constitutively recognizes, binds,
and phosphorylates initially unphosphorylated b subunits of
the AChR. Src-mediated phosphorylation of the b subunit may
involve Tyr-357 but is more likely to occur on Tyr-390; the
corresponding tyrosine of the Torpedo AChR is phosphorylated
and the flanking amino acids show features of consensus tyro-
sine phosphorylation sites (34). Detailed analysis reveals that
the residues surrounding Tyr-390 resemble sites phosphoryl-
ated by receptor tyrosine kinases more closely than motifs
preferred by cytosolic kinases (34). Our observation that Src
phosphorylates the b9 region, however, still renders Tyr-390 a
potential substrate for this kinase. Adsorption with fusion pro-
teins followed by phosphorylation revealed that the b exon
9-homologous regions of d and g fail to associate with tyrosine-
phosphorylating activity (data not shown), which correlates
with the inability of Src family kinases to bind to these regions.
This specificity is notable, because the AChR isolated from
postsynaptic membranes of the Torpedo electric organ can be
tyrosine-phosphorylated in vitro at a high stoichiometry on its
b, g, and d subunits (9) and because the critical b and d tyrosine
residues are conserved in the mouse AChR subunits. The se-
lective binding of the unphosphorylated b subunit, but not the
d or g subunits, to Src, suggests that this interaction may be
relevant to AChR phosphorylation during synaptogenesis at
the mammalian neuromuscular junction.
As binding of theb exon 9 region to Src is not phosphotyrosine-
dependent, it does not appear to involve the SH2 domain of Src.
Apart from the catalytic region, Src contains two other func-
tional domains that could be responsible for binding to the b
exon 9 segment, its unique N-terminal domain and its SH3
domain (29, 30, 33). The exon 9 region of b contains 10 prolines,
whereas the corresponding g and d segments only show 5 and
4, respectively. However, since the proline residues in b are
distributed throughout the exon 9 region and do not show the
high proline density found in typical polyproline-SH3 domain
interactions (35, 36), we assume that binding to b does not
occur via the SH3 domain of Src. Binding may rather involve
the unique domain of Src, as the unique domains of Src-related
kinases have been shown to mediate constitutive binding to a
FIG. 7. AChRs from C2 myotubes are co-isolated with the Src
family kinases Src and Fyn. AChRs were isolated from C2 myotube
lysates as described in the legend to Fig. 6, with the exception of control
isolations with nonconjugated Sepharose. Kinases (arrowhead) were
analyzed by specific immunoblotting. A fraction (0.03%) of the initial
lysate was included as a standard (L). Quantitation of immunoblots
shows that under these conditions ;0.04% of Fyn and ;0.01% of Src
present in the initial lysate are recovered with toxin-Sepharose. In
src-CT immunoblots this value is ;0.02%. Replacing digitonin with
Nonidet P-40 produced similar results.
FIG. 6. Specific co-isolation of a Src-related kinase(s) with the
AChR from C2 myotubes. C2 myotubes were lysed in a buffer con-
taining 1% digitonin. AChRs were isolated by an incubation for 2 h at
4 °C with a-bungarotoxin conjugated to Sepharose beads. As controls,
we either added 10 mM excess free toxin to the lysate to compete for
AChR binding to toxin-Sepharose, or we used nonconjugated Sepharose
beads. A, analysis of co-isolated Src-related kinase(s) was performed by
immunoblotting with src-CT. One or several kinases were isolated in a
specific manner with toxin-Sepharose beads (solid arrowhead). The
;90-kDa src-CT-reactive, contaminating band represented nonspecific
binding as it was found in both control and experimental samples. A
fraction of the initial cell lysate was analyzed as a control (L). B, the
nitrocellulose membrane was stripped and reprobed with an antibody
recognizing phosphotyrosine. C, a second reprobing of the same blot was
performed with antibody m124 reactive with the AChR b subunit. The
absence and presence of the b subunit (open arrowhead) confirms that
the AChR is specifically isolated with toxin-Sepharose. In this experi-
ment, the amount of the control lysate loaded (L) was too small for the
b subunit to be visualized with m124 antiserum. Analysis shows that
one or several Src-related kinases are co-isolated with the AChR and
that the kinase(s) and the b subunit of the AChR are tyrosine-phospho-
rylated. Similar results were obtained when using Nonidet P-40 instead
of digitonin as the detergent.
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number of transmembrane receptors (29). For example, the
unique region of Lck is responsible for its association with CD4
(37), and binding to components of the T- and B-cell receptors
has been shown to involve the unique domains of Fyn and Lyn
(38, 39). Interestingly, to our knowledge, no constitutive inter-
actions have been described between Src and transmembrane
proteins lacking kinase activity, although Src is well known to
bind via its SH2 domain to activated, phosphorylated receptor
tyrosine kinases such as the platelet-derived growth factor
receptor (40). Our observed binding of Src to the b subunit of
the AChR may thus represent a class of Src interactions that is
specific for differentiated post-mitotic cells such as myotubes.
One possibility that we cannot exclude is that a third, ancillary
protein mediates the binding of Src to the b exon 9 region. If
such a protein is involved, however, it is not subject to tyrosine
phosphorylation, as our assays did not identify any phospho-
rylated proteins other than Src and the fusion proteins.
None of the GST fusion proteins tested bound to Fyn or Yes,
yet AChRs isolated from C2 myotubes by a-bungarotoxin-
Sepharose are associated with Fyn as well as with Src. While
we cannot exclude the possibility that association of the AChR
with Fyn involves one or several domains of the receptor not
covered by our fusion proteins, it seems most likely that this
association involves an interaction between the tyrosine-phos-
phorylated AChR b subunit and the Fyn SH2 domain. This
inference is based on the observations that in C2 myotubes the
b subunit of the AChR is tyrosine-phosphorylated (Fig. 6) and
that in the electric organ of Torpedo phosphorylated AChRs are
associated with the SH2 domains of two kinases of the Src
family, Fyn and Fyk (10, 11). In co-immunoprecipitation exper-
iments, Fyn interacted both with phosphorylated d and b sub-
units, whereas Fyk preferentially interacted with phosphoryl-
ated d subunits. Expression of Fyk, a Src-related kinase with
homologies to Fyn and Yes, has not been reported in organisms
other than Torpedo. Furthermore, in our precipitates with
a-bungarotoxin-Sepharose, we failed to detect tyrosine-phos-
phorylated proteins other than the AChR b subunit, Src, or
Fyn. Together, these findings suggest that abundant tyrosine
phosphorylation of the AChR d subunit, as well as binding of
Fyk to phosphorylated d, may occur specifically in the electric
organ of Torpedo but not in mammalian muscle. In mammalian
C2 myotubes, on the other hand, our findings suggest a model
in which newly synthesized, unphosphorylated AChRs are ini-
tially tyrosine-phosphorylated by Src on their b subunits. The
phosphorylated b subunits may then interact with the SH2
domain of Fyn. Src may remain bound to the b subunits to yield
a FynzSrczAChR complex or dissociate from the AChR prior to
its association with Fyn.
What is the functional significance of the association of the
AChR with Src and Fyn in C2 myotubes? The most likely
hypothesis is that AChR phosphorylation is related to cluster-
ing and immobilization of the AChR in the myotube membrane.
Phosphotyrosine labeling, as observed by immunofluorescence,
is concentrated both at the mature synapse and at AChR clus-
ters in developing myotubes (14, 15, 19). In addition, a variety
of physiological and nonphysiological stimuli that result in
AChR aggregation, including agrin, neuregulin, basic fibro-
blast growth factor, polymer beads, and electric fields, appear
to act through mechanisms that involve protein-tyrosine ki-
nase activation (18, 41–44). A number of postsynaptic proteins
such as b-dystroglycan, syntrophin, paxillin, the 87-kDa pro-
tein, or dystrophin contain tyrosine phosphorylation consensus
sites or have been shown to be tyrosine-phosphorylated in
Torpedo electric organ (45–49). In our experiments with un-
stimulated C2 myotubes, small but significant fractions of the
total kinases present in C2 cells are associated with the AChRs,
;1% of the total Fyn and ;0.25% of the total Src. Considering
the high level of AChR expression in C2 myotubes, we thus
expect only a small proportion of surface AChRs to be associ-
ated with Src and Fyn. C2 myotubes spontaneously form a
small number of AChR clusters (27), and the phosphorylated
AChRs and those associated with kinases could represent
AChRs that are in the process of spontaneous cluster forma-
tion. Such a mechanism could involve phosphorylation of crit-
ical muscle proteins by AChR-associated Src and/or Fyn ki-
nases and subsequent immobilization of phosphorylated
AChRs by protein-protein recognition mediated by SH2 do-
main-phosphotyrosine interactions. In agreement with this
idea, immunofluorescence studies have shown that C2 myo-
tubes contain some domains composed of coextensive aggre-
gates of phosphotyrosine and AChRs (19).
An important question raised by these experiments is
whether Src and Fyn are part of the agrin signaling pathway.
A number of experimental observations link tyrosine phospho-
rylation of the AChR with agrin-induced clustering. After
treatment with agrin, tyrosine phosphorylation of the AChR
occurs before AChR clustering, and inhibitors that block tyro-
sine phosphorylation of the AChR also block clustering (20, 21,
50). The agrin dose-response curve is the same for both events,
and the two are correlated under several different conditions
(20). Agrin has recently been shown to act via a receptor tyro-
sine kinase, MuSK, which apparently acts as part of a receptor
complex involving other, unidentified proteins (23). Activation
of MuSK has been shown to result in both autophosphorylation
and tyrosine phosphorylation of the AChR (23, 24). Thus, al-
though the intracellular signaling pathway by which agrin
induces AChR clustering is unknown, it appears to involve
activation of protein-tyrosine kinases and tyrosine phosphoryl-
ation, perhaps of the AChR itself.
A possible interpretation of the association of Fyn and Src
with the AChR in unstimulated cells and its relevance for
agrin’s signaling pathway is suggested by consideration of
other receptors. Several signaling receptors that lack intrinsic
tyrosine kinase activities, such as cytokine (e.g. interleukin-2)
and lymphocyte (e.g. T-cell and B-cell) receptors, are hetero-
oligomeric transmembrane proteins that constitutively associ-
ate with nonreceptor tyrosine kinases of the Jak and Src fam-
ily, respectively, before onset of signaling (51–53). Upon
extracellular stimulation with ligand, the cytoplasmic kinases
associated with the receptors phosphorylate them, thereby be-
ginning the signaling cascade. In a similar way, activation of
the agrin receptor could, through as yet undefined steps, result
in phosphorylation of the AChR by bound Src or Fyn and in
increased association of the AChR with Fyn. This may then
lead to phosphorylation of other postsynaptic proteins and/or
their association with the AChR. Alternatively, tyrosine phos-
phorylation of the AChR may be unrelated to the initial clus-
tering events but rather to downstream events in the pathway
regulating AChR aggregation. Accordingly, the initial cluster-
ing of AChRs, leading to formation of microclusters, could itself
result in activation of receptor-associated Src or Fyn. Tyrosine
phosphorylation of the AChR might thus be related to enlarge-
ment and stabilization of the clusters or to the recruitment of
other proteins to the aggregates. In any case, the elucidation of
the signaling pathways and the protein-protein interactions
related to AChR clustering is an important area of future
research. Our experiments indicate that Src and Fyn, associ-
ated with the AChR, are likely to play important roles in these
pathways.
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Note Added in Proof—Holmes et al. (Holmes, T. C., Fadool, D. A.,
Ren, R., and Levitan, I. B. (1996) Science, in press) have found that the
potassium channel, hKv1.5, is also associated Src tyrosine kinase and
that the channel is tyrosine-phosphorylated. Regulation of ionic channel
function via interaction with Src may thus be a general phenomenon.
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